HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yutaka Takahashi Selected Research

dihydroouabain

1/2020Dihydroouabain, a novel radiosensitizer for cervical cancer identified by automated high-throughput screening.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yutaka Takahashi Research Topics

Disease

83Neoplasms (Cancer)
12/2022 - 01/2002
19Neoplasm Metastasis (Metastasis)
09/2021 - 11/2002
12Carcinoma (Carcinomatosis)
01/2020 - 11/2002
11Autoimmune Hypophysitis
01/2022 - 01/2014
10Hypophysitis
01/2022 - 01/2014
10Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2019 - 07/2003
9Hypothyroidism
12/2021 - 04/2007
9Acromegaly
10/2019 - 01/2008
8Hepatocellular Carcinoma (Hepatoma)
01/2019 - 09/2007
8Non-alcoholic Fatty Liver Disease
01/2018 - 03/2007
8Prostatic Neoplasms (Prostate Cancer)
01/2015 - 03/2003
8Stomach Neoplasms (Stomach Cancer)
01/2014 - 11/2002
7Osteosarcoma (Osteogenic Sarcoma)
04/2022 - 01/2005
7Colonic Neoplasms (Colon Cancer)
01/2011 - 11/2002
6Paraneoplastic Syndromes (Paraneoplastic Syndrome)
01/2022 - 10/2018
5Inflammation (Inflammations)
12/2021 - 12/2007
5Adenocarcinoma of Lung
11/2021 - 05/2013
5Atherosclerosis
11/2021 - 01/2003
5Breast Neoplasms (Breast Cancer)
09/2021 - 07/2004
5Hypersensitivity (Allergy)
01/2021 - 12/2017
5Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2020 - 02/2004
4Atopic Dermatitis (Atopic Eczema)
12/2022 - 12/2003
4Type 1 Diabetes Mellitus (Autoimmune Diabetes)
09/2022 - 01/2014
4Pituitary ACTH Hypersecretion
06/2022 - 11/2020
4Interstitial Lung Diseases (Interstitial Lung Disease)
01/2022 - 05/2013
4Pituitary Neoplasms (Pituitary Adenoma)
07/2021 - 01/2014
4Hypoglycemia (Reactive Hypoglycemia)
08/2019 - 01/2009
4Obesity
01/2016 - 04/2007
4Lymphatic Metastasis
10/2015 - 11/2002
4Adenocarcinoma
06/2015 - 03/2003
4Muscular Atrophy (Muscle Atrophy)
09/2012 - 02/2008
4Colorectal Neoplasms (Colorectal Cancer)
01/2006 - 08/2003
3Pancreatic Neoplasms (Pancreatic Cancer)
04/2022 - 04/2005
3Fatigue
10/2021 - 09/2008
3Adrenal Insufficiency (Adrenal Gland Hypofunction)
09/2021 - 01/2018
3Autoimmune Diseases (Autoimmune Disease)
03/2021 - 01/2014
3Cushing Syndrome
09/2020 - 01/2014
3Pheochromocytoma
09/2020 - 01/2017
3Adrenocortical Adenoma (Disease, Conn's)
09/2020 - 01/2017
3Lung Neoplasms (Lung Cancer)
08/2020 - 01/2011
3Hypopituitarism (Sheehan's Syndrome)
04/2020 - 04/2007
3Residual Neoplasm
10/2018 - 07/2003
3Paraganglioma (Paragangliomas)
01/2017 - 01/2014
3Insulin Resistance
01/2017 - 03/2007
3Type 2 Diabetes Mellitus (MODY)
01/2016 - 10/2004
3Combined Pituitary Hormone Deficiency
04/2015 - 11/2008
3Carcinogenesis
01/2014 - 08/2012
3Hypertension (High Blood Pressure)
04/2012 - 04/2007

Drug/Important Bio-Agent (IBA)

20Proteins (Proteins, Gene)FDA Link
12/2022 - 09/2002
20Growth Hormone (Somatotropin)IBA
03/2021 - 03/2004
17Insulin-Like Growth Factor I (IGF-1)IBA
10/2018 - 01/2008
13Glucose (Dextrose)FDA LinkGeneric
08/2019 - 12/2007
12Immune Checkpoint InhibitorsIBA
12/2022 - 01/2017
11Adrenocorticotropic Hormone (ACTH)FDA Link
06/2022 - 04/2007
9AntigensIBA
12/2022 - 09/2002
9Insulin (Novolin)FDA Link
09/2022 - 12/2007
9Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
12/2021 - 01/2011
8Pharmaceutical PreparationsIBA
01/2022 - 09/2002
8ProlactinIBA
03/2021 - 11/2008
7AntibodiesIBA
12/2022 - 01/2014
6Hydrocortisone (Cortisol)FDA LinkGeneric
06/2022 - 01/2014
6AutoantibodiesIBA
01/2022 - 09/2002
6Irinotecan (Camptosar)FDA LinkGeneric
01/2021 - 01/2004
5Hormones (Hormone)IBA
01/2022 - 09/2004
5LigandsIBA
12/2021 - 01/2018
4Immunoglobulin E (IgE)IBA
12/2021 - 06/2002
4LipidsIBA
11/2021 - 03/2007
4Tumor Biomarkers (Tumor Markers)IBA
07/2021 - 04/2005
4GlucocorticoidsIBA
06/2021 - 04/2007
4Transcription Factors (Transcription Factor)IBA
03/2021 - 03/2015
4Immunoglobulin G (IgG)IBA
01/2021 - 02/2014
4Isolated ACTH DeficiencyIBA
04/2020 - 02/2014
4Reactive Oxygen Species (Oxygen Radicals)IBA
08/2012 - 03/2007
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2011 - 11/2002
4Messenger RNA (mRNA)IBA
02/2008 - 11/2002
4beta CateninIBA
08/2007 - 03/2003
3AllergensIBA
12/2022 - 12/2017
3PapainIBA
12/2022 - 01/2021
3CarbonIBA
04/2022 - 01/2005
3Biological ProductsIBA
04/2022 - 01/2005
3Differentiation AntigensIBA
01/2022 - 08/2004
3DNA (Deoxyribonucleic Acid)IBA
01/2022 - 05/2020
3Radiation-Sensitizing AgentsIBA
01/2022 - 09/2019
3CytokinesIBA
12/2021 - 01/2004
3Phosphotransferases (Kinase)IBA
11/2021 - 09/2005
3GemcitabineFDA Link
01/2021 - 04/2005
3Epinephrine (Adrenaline)FDA LinkGeneric
01/2020 - 01/2013
3Formaldehyde (Formol)FDA Link
05/2019 - 11/2002
3ErbB Receptors (EGF Receptor)IBA
03/2018 - 08/2010
3Tyrosine Kinase InhibitorsIBA
03/2018 - 08/2010
3Indicators and Reagents (Reagents)IBA
01/2018 - 09/2012
3CarbohydratesIBA
08/2011 - 01/2003

Therapy/Procedure

38Therapeutics
04/2022 - 09/2002
26Radiotherapy
12/2022 - 03/2003
16Drug Therapy (Chemotherapy)
04/2022 - 07/2003
9Hepatectomy
07/2020 - 07/2011
7Immunotherapy
12/2022 - 08/2007
7Brachytherapy
05/2014 - 02/2008
6Adjuvant Chemotherapy
11/2021 - 01/2004
4Heavy Ion Radiotherapy
04/2022 - 07/2003